Trial Profile
An open-label study assessing pharmacokinetics of single and multiple doses of peramivir in healthy Chinese subjects.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jun 2016
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- 27 Jun 2016 New trial record
- 17 Jun 2016 Results published in the Clinical Drug Investigation